Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)
Clinical trial NCT04515615 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04515615
- Sponsor
- Yu jiren
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2023-12-29
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.